Advertisement
U.S. Markets closed

NanoVibronix, Inc. (NAOV)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
0.5460+0.0261 (+5.02%)
At close: 04:00PM EDT
0.5434 -0.00 (-0.48%)
After hours: 07:50PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close0.5199
Open0.5400
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.5200 - 0.5680
52 Week Range0.4580 - 1.5500
Volume90,243
Avg. Volume124,115
Market Cap1.52M
Beta (5Y Monthly)1.50
PE Ratio (TTM)N/A
EPS (TTM)-1.2900
Earnings DateNov 11, 2024 - Nov 15, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Business Wire

    NanoVibronix Takes Next Step to Partner with Specialist Urology Company to Expand Sales of UroShield in Germany

    ELMSFORD, N.Y., October 09, 2024--NanoVibronix, Inc., (NASDAQ: NAOV) (the "Company"), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave ("SAW") Portable Ultrasonic Therapeutic Devices, today announced it has signed a non-binding term sheet for a license and supply agreement with APOGEPHA Arzneimittel GmbH ("APOGEPHA"), a German pharmaceutical company, which specializes in the development, marketing, sales and distribution of urology product

  • Business Wire

    NanoVibronix Signs Letter of Intent with Potential New Distributor

    ELMSFORD, N.Y., September 23, 2024--NanoVibronix, Inc., (NASDAQ: NAOV) (the "Company"), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced it has signed a letter of intent with Medici Medical LTD ("Medici"), a leading distributor of medical products in the Israeli healthcare market, to explore the opportunities for distribution of the Company’s UroShield device in Israel.